CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

NCT00659425 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Non-Hodgkin's Lymphoma

Interventions

DRUG: CAT-8015 (Moxetumomab Pasudotox)
DRUG: CAT-8015 (Moxetumomab Pasudotox)
DRUG: CAT-8015 (Moxetumomab Pasudotox)
DRUG: CAT-8015 (Moxetumomab Pasudotox)
DRUG: CAT-8015 (Moxetumomab Pasudotox)
DRUG: CAT-8015 (Moxetumomab Pasudotox)
DRUG: CAT-8015 (Moxetumomab Pasudotox)
DRUG: CAT-8015 (Moxetumomab Pasudotox)
DRUG: CAT-8015 (Moxetumomab Pasudotox)
DRUG: CAT-8015 (Moxetumomab Pasudotox)

Sponsor

MedImmune LLC

Collaborators

[object Object]